To evaluate efficacy, clinical changes and corneal ultrastructural modifications after therapy with Cenegermin (recombinant human nerve growth factor) eye drops for the treatment of moderate-severe neurotrophic keratopathy (NK) by in vivo corneal microscopy (IVCM) and anterior segment optical coherence tomography (AS-OCT)
Corneal ultrastructural modifications after therapy with Cenegermin eye drops for the treatment of moderate-severe neurotrophic keratopathy
F SemeraroProject Administration
2019-01-01
Abstract
To evaluate efficacy, clinical changes and corneal ultrastructural modifications after therapy with Cenegermin (recombinant human nerve growth factor) eye drops for the treatment of moderate-severe neurotrophic keratopathy (NK) by in vivo corneal microscopy (IVCM) and anterior segment optical coherence tomography (AS-OCT)File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Corneal ultrastructural modifications after therapy with Cenegermin eye drops for the treatment of moderate-severe neurotrophic keratopathy _ IOVS _ ARVO Journals.pdf
gestori archivio
Descrizione: Cenegermin abs, 2019, Arvo 2019
Tipologia:
Abstract
Licenza:
DRM non definito
Dimensione
149.4 kB
Formato
Adobe PDF
|
149.4 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
